Industry Research Reports

Home > Reports > Medical Devices & Consumables > Medical 3D Bioprinting- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Medical 3D Bioprinting- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 151 Pages

Report ld: 3465317

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Medical 3D Bioprinting was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Medical 3D bioprinting is the use of 3D printing-like techniques to combine cells, growth factors or biological materials to create biomedical parts, often with the aim of mimicking natural tissue characteristics. In general, 3D bioprinting can utilize a layer-by-layer approach to deposit materials called bioinks to create tissue-like structures that are subsequently used in various fields of medicine and tissue engineering. Bioprinting covers a wide range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to aid in the study of drugs and potential treatments.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Medical 3D Bioprinting, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical 3D Bioprinting by region & country, by Type, and by Application.

The Medical 3D Bioprinting market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical 3D Bioprinting.

MARKET SEGMENTATION

By Company

3D Systems
GE Healthcare
ExOne
Electro Optical Systems
Renishaw
Stratasys
EnvisionTEC
Cyfuse Biomedical
Formlabs
Organovo Holdings
Allevi
Advanced Solutions
Aspect Biosystems
CELLINK
GeSiM
Bio3D Technologies
Regenovo Biotechnology
Optomec
Mecuris
Fluicell
BigRep

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

SLA
FDM
LOM
Others

Segment by Application

Medical Device Manufacturers
Pharmaceutical Companies
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Medical 3D Bioprinting company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Medical 3D Bioprinting in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Medical 3D Bioprinting in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Medical 3D Bioprinting Product Introduction

1.2 Global Medical 3D Bioprinting Market Size Forecast (2020-2031)

1.3 Medical 3D Bioprinting Market Trends & Drivers

1.3.1 Medical 3D Bioprinting Industry Trends

1.3.2 Medical 3D Bioprinting Market Drivers & Opportunity

1.3.3 Medical 3D Bioprinting Market Challenges

1.3.4 Medical 3D Bioprinting Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Medical 3D Bioprinting Players Revenue Ranking (2024)

2.2 Global Medical 3D Bioprinting Revenue by Company (2020-2025)

2.3 Key Companies Medical 3D Bioprinting Manufacturing Base Distribution and Headquarters

2.4 Key Companies Medical 3D Bioprinting Product Offered

2.5 Key Companies Time to Begin Mass Production of Medical 3D Bioprinting

2.6 Medical 3D Bioprinting Market Competitive Analysis

2.6.1 Medical 3D Bioprinting Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Medical 3D Bioprinting Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical 3D Bioprinting as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 SLA

3.1.2 FDM

3.1.3 LOM

3.1.4 Others

3.2 Global Medical 3D Bioprinting Sales Value by Type

3.2.1 Global Medical 3D Bioprinting Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Medical 3D Bioprinting Sales Value, by Type (2020-2031)

3.2.3 Global Medical 3D Bioprinting Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Medical Device Manufacturers

4.1.2 Pharmaceutical Companies

4.1.3 Others

4.2 Global Medical 3D Bioprinting Sales Value by Application

4.2.1 Global Medical 3D Bioprinting Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Medical 3D Bioprinting Sales Value, by Application (2020-2031)

4.2.3 Global Medical 3D Bioprinting Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Medical 3D Bioprinting Sales Value by Region

5.1.1 Global Medical 3D Bioprinting Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Medical 3D Bioprinting Sales Value by Region (2020-2025)

5.1.3 Global Medical 3D Bioprinting Sales Value by Region (2026-2031)

5.1.4 Global Medical 3D Bioprinting Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Medical 3D Bioprinting Sales Value, 2020-2031

5.2.2 North America Medical 3D Bioprinting Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Medical 3D Bioprinting Sales Value, 2020-2031

5.3.2 Europe Medical 3D Bioprinting Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Medical 3D Bioprinting Sales Value, 2020-2031

5.4.2 Asia Pacific Medical 3D Bioprinting Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Medical 3D Bioprinting Sales Value, 2020-2031

5.5.2 South America Medical 3D Bioprinting Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Medical 3D Bioprinting Sales Value, 2020-2031

5.6.2 Middle East & Africa Medical 3D Bioprinting Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Medical 3D Bioprinting Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Medical 3D Bioprinting Sales Value, 2020-2031

6.3 United States

6.3.1 United States Medical 3D Bioprinting Sales Value, 2020-2031

6.3.2 United States Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Medical 3D Bioprinting Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Medical 3D Bioprinting Sales Value, 2020-2031

6.4.2 Europe Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Medical 3D Bioprinting Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Medical 3D Bioprinting Sales Value, 2020-2031

6.5.2 China Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

6.5.3 China Medical 3D Bioprinting Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Medical 3D Bioprinting Sales Value, 2020-2031

6.6.2 Japan Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Medical 3D Bioprinting Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Medical 3D Bioprinting Sales Value, 2020-2031

6.7.2 South Korea Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Medical 3D Bioprinting Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Medical 3D Bioprinting Sales Value, 2020-2031

6.8.2 Southeast Asia Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Medical 3D Bioprinting Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Medical 3D Bioprinting Sales Value, 2020-2031

6.9.2 India Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

6.9.3 India Medical 3D Bioprinting Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 3D Systems

7.1.1 3D Systems Profile

7.1.2 3D Systems Main Business

7.1.3 3D Systems Medical 3D Bioprinting Products, Services and Solutions

7.1.4 3D Systems Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.1.5 3D Systems Recent Developments

7.2 GE Healthcare

7.2.1 GE Healthcare Profile

7.2.2 GE Healthcare Main Business

7.2.3 GE Healthcare Medical 3D Bioprinting Products, Services and Solutions

7.2.4 GE Healthcare Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.2.5 GE Healthcare Recent Developments

7.3 ExOne

7.3.1 ExOne Profile

7.3.2 ExOne Main Business

7.3.3 ExOne Medical 3D Bioprinting Products, Services and Solutions

7.3.4 ExOne Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.3.5 ExOne Recent Developments

7.4 Electro Optical Systems

7.4.1 Electro Optical Systems Profile

7.4.2 Electro Optical Systems Main Business

7.4.3 Electro Optical Systems Medical 3D Bioprinting Products, Services and Solutions

7.4.4 Electro Optical Systems Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.4.5 Electro Optical Systems Recent Developments

7.5 Renishaw

7.5.1 Renishaw Profile

7.5.2 Renishaw Main Business

7.5.3 Renishaw Medical 3D Bioprinting Products, Services and Solutions

7.5.4 Renishaw Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.5.5 Renishaw Recent Developments

7.6 Stratasys

7.6.1 Stratasys Profile

7.6.2 Stratasys Main Business

7.6.3 Stratasys Medical 3D Bioprinting Products, Services and Solutions

7.6.4 Stratasys Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.6.5 Stratasys Recent Developments

7.7 EnvisionTEC

7.7.1 EnvisionTEC Profile

7.7.2 EnvisionTEC Main Business

7.7.3 EnvisionTEC Medical 3D Bioprinting Products, Services and Solutions

7.7.4 EnvisionTEC Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.7.5 EnvisionTEC Recent Developments

7.8 Cyfuse Biomedical

7.8.1 Cyfuse Biomedical Profile

7.8.2 Cyfuse Biomedical Main Business

7.8.3 Cyfuse Biomedical Medical 3D Bioprinting Products, Services and Solutions

7.8.4 Cyfuse Biomedical Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.8.5 Cyfuse Biomedical Recent Developments

7.9 Formlabs

7.9.1 Formlabs Profile

7.9.2 Formlabs Main Business

7.9.3 Formlabs Medical 3D Bioprinting Products, Services and Solutions

7.9.4 Formlabs Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.9.5 Formlabs Recent Developments

7.10 Organovo Holdings

7.10.1 Organovo Holdings Profile

7.10.2 Organovo Holdings Main Business

7.10.3 Organovo Holdings Medical 3D Bioprinting Products, Services and Solutions

7.10.4 Organovo Holdings Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.10.5 Organovo Holdings Recent Developments

7.11 Allevi

7.11.1 Allevi Profile

7.11.2 Allevi Main Business

7.11.3 Allevi Medical 3D Bioprinting Products, Services and Solutions

7.11.4 Allevi Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.11.5 Allevi Recent Developments

7.12 Advanced Solutions

7.12.1 Advanced Solutions Profile

7.12.2 Advanced Solutions Main Business

7.12.3 Advanced Solutions Medical 3D Bioprinting Products, Services and Solutions

7.12.4 Advanced Solutions Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.12.5 Advanced Solutions Recent Developments

7.13 Aspect Biosystems

7.13.1 Aspect Biosystems Profile

7.13.2 Aspect Biosystems Main Business

7.13.3 Aspect Biosystems Medical 3D Bioprinting Products, Services and Solutions

7.13.4 Aspect Biosystems Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.13.5 Aspect Biosystems Recent Developments

7.14 CELLINK

7.14.1 CELLINK Profile

7.14.2 CELLINK Main Business

7.14.3 CELLINK Medical 3D Bioprinting Products, Services and Solutions

7.14.4 CELLINK Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.14.5 CELLINK Recent Developments

7.15 GeSiM

7.15.1 GeSiM Profile

7.15.2 GeSiM Main Business

7.15.3 GeSiM Medical 3D Bioprinting Products, Services and Solutions

7.15.4 GeSiM Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.15.5 GeSiM Recent Developments

7.16 Bio3D Technologies

7.16.1 Bio3D Technologies Profile

7.16.2 Bio3D Technologies Main Business

7.16.3 Bio3D Technologies Medical 3D Bioprinting Products, Services and Solutions

7.16.4 Bio3D Technologies Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.16.5 Bio3D Technologies Recent Developments

7.17 Regenovo Biotechnology

7.17.1 Regenovo Biotechnology Profile

7.17.2 Regenovo Biotechnology Main Business

7.17.3 Regenovo Biotechnology Medical 3D Bioprinting Products, Services and Solutions

7.17.4 Regenovo Biotechnology Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.17.5 Regenovo Biotechnology Recent Developments

7.18 Optomec

7.18.1 Optomec Profile

7.18.2 Optomec Main Business

7.18.3 Optomec Medical 3D Bioprinting Products, Services and Solutions

7.18.4 Optomec Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.18.5 Optomec Recent Developments

7.19 Mecuris

7.19.1 Mecuris Profile

7.19.2 Mecuris Main Business

7.19.3 Mecuris Medical 3D Bioprinting Products, Services and Solutions

7.19.4 Mecuris Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.19.5 Mecuris Recent Developments

7.20 Fluicell

7.20.1 Fluicell Profile

7.20.2 Fluicell Main Business

7.20.3 Fluicell Medical 3D Bioprinting Products, Services and Solutions

7.20.4 Fluicell Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.20.5 Fluicell Recent Developments

7.21 BigRep

7.21.1 BigRep Profile

7.21.2 BigRep Main Business

7.21.3 BigRep Medical 3D Bioprinting Products, Services and Solutions

7.21.4 BigRep Medical 3D Bioprinting Revenue (US$ Million) & (2020-2025)

7.21.5 BigRep Recent Developments

8 Industry Chain Analysis

8.1 Medical 3D Bioprinting Industrial Chain

8.2 Medical 3D Bioprinting Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Medical 3D Bioprinting Sales Model

8.5.2 Sales Channel

8.5.3 Medical 3D Bioprinting Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Medical 3D Bioprinting Market Trends

Table 2. Medical 3D Bioprinting Market Drivers & Opportunity

Table 3. Medical 3D Bioprinting Market Challenges

Table 4. Medical 3D Bioprinting Market Restraints

Table 5. Global Medical 3D Bioprinting Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Medical 3D Bioprinting Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Medical 3D Bioprinting Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Medical 3D Bioprinting Product Type

Table 9. Key Companies Time to Begin Mass Production of Medical 3D Bioprinting

Table 10. Global Medical 3D Bioprinting Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical 3D Bioprinting as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Medical 3D Bioprinting Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Medical 3D Bioprinting Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Medical 3D Bioprinting Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Medical 3D Bioprinting Sales Market Share in Value by Type (2020-2025)

Table 17. Global Medical 3D Bioprinting Sales Market Share in Value by Type (2026-2031)

Table 18. Global Medical 3D Bioprinting Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Medical 3D Bioprinting Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Medical 3D Bioprinting Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Medical 3D Bioprinting Sales Market Share in Value by Application (2020-2025)

Table 22. Global Medical 3D Bioprinting Sales Market Share in Value by Application (2026-2031)

Table 23. Global Medical 3D Bioprinting Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Medical 3D Bioprinting Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Medical 3D Bioprinting Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Medical 3D Bioprinting Sales Value by Region (2020-2025) & (%)

Table 27. Global Medical 3D Bioprinting Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Medical 3D Bioprinting Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Medical 3D Bioprinting Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Medical 3D Bioprinting Sales Value, (2026-2031) & (US$ Million)

Table 31. 3D Systems Basic Information List

Table 32. 3D Systems Description and Business Overview

Table 33. 3D Systems Medical 3D Bioprinting Products, Services and Solutions

Table 34. Revenue (US$ Million) in Medical 3D Bioprinting Business of 3D Systems (2020-2025)

Table 35. 3D Systems Recent Developments

Table 36. GE Healthcare Basic Information List

Table 37. GE Healthcare Description and Business Overview

Table 38. GE Healthcare Medical 3D Bioprinting Products, Services and Solutions

Table 39. Revenue (US$ Million) in Medical 3D Bioprinting Business of GE Healthcare (2020-2025)

Table 40. GE Healthcare Recent Developments

Table 41. ExOne Basic Information List

Table 42. ExOne Description and Business Overview

Table 43. ExOne Medical 3D Bioprinting Products, Services and Solutions

Table 44. Revenue (US$ Million) in Medical 3D Bioprinting Business of ExOne (2020-2025)

Table 45. ExOne Recent Developments

Table 46. Electro Optical Systems Basic Information List

Table 47. Electro Optical Systems Description and Business Overview

Table 48. Electro Optical Systems Medical 3D Bioprinting Products, Services and Solutions

Table 49. Revenue (US$ Million) in Medical 3D Bioprinting Business of Electro Optical Systems (2020-2025)

Table 50. Electro Optical Systems Recent Developments

Table 51. Renishaw Basic Information List

Table 52. Renishaw Description and Business Overview

Table 53. Renishaw Medical 3D Bioprinting Products, Services and Solutions

Table 54. Revenue (US$ Million) in Medical 3D Bioprinting Business of Renishaw (2020-2025)

Table 55. Renishaw Recent Developments

Table 56. Stratasys Basic Information List

Table 57. Stratasys Description and Business Overview

Table 58. Stratasys Medical 3D Bioprinting Products, Services and Solutions

Table 59. Revenue (US$ Million) in Medical 3D Bioprinting Business of Stratasys (2020-2025)

Table 60. Stratasys Recent Developments

Table 61. EnvisionTEC Basic Information List

Table 62. EnvisionTEC Description and Business Overview

Table 63. EnvisionTEC Medical 3D Bioprinting Products, Services and Solutions

Table 64. Revenue (US$ Million) in Medical 3D Bioprinting Business of EnvisionTEC (2020-2025)

Table 65. EnvisionTEC Recent Developments

Table 66. Cyfuse Biomedical Basic Information List

Table 67. Cyfuse Biomedical Description and Business Overview

Table 68. Cyfuse Biomedical Medical 3D Bioprinting Products, Services and Solutions

Table 69. Revenue (US$ Million) in Medical 3D Bioprinting Business of Cyfuse Biomedical (2020-2025)

Table 70. Cyfuse Biomedical Recent Developments

Table 71. Formlabs Basic Information List

Table 72. Formlabs Description and Business Overview

Table 73. Formlabs Medical 3D Bioprinting Products, Services and Solutions

Table 74. Revenue (US$ Million) in Medical 3D Bioprinting Business of Formlabs (2020-2025)

Table 75. Formlabs Recent Developments

Table 76. Organovo Holdings Basic Information List

Table 77. Organovo Holdings Description and Business Overview

Table 78. Organovo Holdings Medical 3D Bioprinting Products, Services and Solutions

Table 79. Revenue (US$ Million) in Medical 3D Bioprinting Business of Organovo Holdings (2020-2025)

Table 80. Organovo Holdings Recent Developments

Table 81. Allevi Basic Information List

Table 82. Allevi Description and Business Overview

Table 83. Allevi Medical 3D Bioprinting Products, Services and Solutions

Table 84. Revenue (US$ Million) in Medical 3D Bioprinting Business of Allevi (2020-2025)

Table 85. Allevi Recent Developments

Table 86. Advanced Solutions Basic Information List

Table 87. Advanced Solutions Description and Business Overview

Table 88. Advanced Solutions Medical 3D Bioprinting Products, Services and Solutions

Table 89. Revenue (US$ Million) in Medical 3D Bioprinting Business of Advanced Solutions (2020-2025)

Table 90. Advanced Solutions Recent Developments

Table 91. Aspect Biosystems Basic Information List

Table 92. Aspect Biosystems Description and Business Overview

Table 93. Aspect Biosystems Medical 3D Bioprinting Products, Services and Solutions

Table 94. Revenue (US$ Million) in Medical 3D Bioprinting Business of Aspect Biosystems (2020-2025)

Table 95. Aspect Biosystems Recent Developments

Table 96. CELLINK Basic Information List

Table 97. CELLINK Description and Business Overview

Table 98. CELLINK Medical 3D Bioprinting Products, Services and Solutions

Table 99. Revenue (US$ Million) in Medical 3D Bioprinting Business of CELLINK (2020-2025)

Table 100. CELLINK Recent Developments

Table 101. GeSiM Basic Information List

Table 102. GeSiM Description and Business Overview

Table 103. GeSiM Medical 3D Bioprinting Products, Services and Solutions

Table 104. Revenue (US$ Million) in Medical 3D Bioprinting Business of GeSiM (2020-2025)

Table 105. GeSiM Recent Developments

Table 106. Bio3D Technologies Basic Information List

Table 107. Bio3D Technologies Description and Business Overview

Table 108. Bio3D Technologies Medical 3D Bioprinting Products, Services and Solutions

Table 109. Revenue (US$ Million) in Medical 3D Bioprinting Business of Bio3D Technologies (2020-2025)

Table 110. Bio3D Technologies Recent Developments

Table 111. Regenovo Biotechnology Basic Information List

Table 112. Regenovo Biotechnology Description and Business Overview

Table 113. Regenovo Biotechnology Medical 3D Bioprinting Products, Services and Solutions

Table 114. Revenue (US$ Million) in Medical 3D Bioprinting Business of Regenovo Biotechnology (2020-2025)

Table 115. Regenovo Biotechnology Recent Developments

Table 116. Optomec Basic Information List

Table 117. Optomec Description and Business Overview

Table 118. Optomec Medical 3D Bioprinting Products, Services and Solutions

Table 119. Revenue (US$ Million) in Medical 3D Bioprinting Business of Optomec (2020-2025)

Table 120. Optomec Recent Developments

Table 121. Mecuris Basic Information List

Table 122. Mecuris Description and Business Overview

Table 123. Mecuris Medical 3D Bioprinting Products, Services and Solutions

Table 124. Revenue (US$ Million) in Medical 3D Bioprinting Business of Mecuris (2020-2025)

Table 125. Mecuris Recent Developments

Table 126. Fluicell Basic Information List

Table 127. Fluicell Description and Business Overview

Table 128. Fluicell Medical 3D Bioprinting Products, Services and Solutions

Table 129. Revenue (US$ Million) in Medical 3D Bioprinting Business of Fluicell (2020-2025)

Table 130. Fluicell Recent Developments

Table 131. BigRep Basic Information List

Table 132. BigRep Description and Business Overview

Table 133. BigRep Medical 3D Bioprinting Products, Services and Solutions

Table 134. Revenue (US$ Million) in Medical 3D Bioprinting Business of BigRep (2020-2025)

Table 135. BigRep Recent Developments

Table 136. Key Raw Materials Lists

Table 137. Raw Materials Key Suppliers Lists

Table 138. Medical 3D Bioprinting Downstream Customers

Table 139. Medical 3D Bioprinting Distributors List

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

Table 143. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Medical 3D Bioprinting Product Picture

Figure 2. Global Medical 3D Bioprinting Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Medical 3D Bioprinting Sales Value (2020-2031) & (US$ Million)

Figure 4. Medical 3D Bioprinting Report Years Considered

Figure 5. Global Medical 3D Bioprinting Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Medical 3D Bioprinting Revenue in 2024

Figure 7. Medical 3D Bioprinting Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. SLA Picture

Figure 9. FDM Picture

Figure 10. LOM Picture

Figure 11. Others Picture

Figure 12. Global Medical 3D Bioprinting Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 13. Global Medical 3D Bioprinting Sales Value Market Share by Type, 2024 & 2031

Figure 14. Product Picture of Medical Device Manufacturers

Figure 15. Product Picture of Pharmaceutical Companies

Figure 16. Product Picture of Others

Figure 17. Global Medical 3D Bioprinting Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 18. Global Medical 3D Bioprinting Sales Value Market Share by Application, 2024 & 2031

Figure 19. North America Medical 3D Bioprinting Sales Value (2020-2031) & (US$ Million)

Figure 20. North America Medical 3D Bioprinting Sales Value by Country (%), 2024 VS 2031

Figure 21. Europe Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 22. Europe Medical 3D Bioprinting Sales Value by Country (%), 2024 VS 2031

Figure 23. Asia Pacific Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 24. Asia Pacific Medical 3D Bioprinting Sales Value by Region (%), 2024 VS 2031

Figure 25. South America Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 26. South America Medical 3D Bioprinting Sales Value by Country (%), 2024 VS 2031

Figure 27. Middle East & Africa Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 28. Middle East & Africa Medical 3D Bioprinting Sales Value by Country (%), 2024 VS 2031

Figure 29. Key Countries/Regions Medical 3D Bioprinting Sales Value (%), (2020-2031)

Figure 30. United States Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 31. United States Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

Figure 32. United States Medical 3D Bioprinting Sales Value by Application (%), 2024 VS 2031

Figure 33. Europe Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 34. Europe Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

Figure 35. Europe Medical 3D Bioprinting Sales Value by Application (%), 2024 VS 2031

Figure 36. China Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 37. China Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

Figure 38. China Medical 3D Bioprinting Sales Value by Application (%), 2024 VS 2031

Figure 39. Japan Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 40. Japan Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

Figure 41. Japan Medical 3D Bioprinting Sales Value by Application (%), 2024 VS 2031

Figure 42. South Korea Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 43. South Korea Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

Figure 44. South Korea Medical 3D Bioprinting Sales Value by Application (%), 2024 VS 2031

Figure 45. Southeast Asia Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 46. Southeast Asia Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

Figure 47. Southeast Asia Medical 3D Bioprinting Sales Value by Application (%), 2024 VS 2031

Figure 48. India Medical 3D Bioprinting Sales Value, (2020-2031) & (US$ Million)

Figure 49. India Medical 3D Bioprinting Sales Value by Type (%), 2024 VS 2031

Figure 50. India Medical 3D Bioprinting Sales Value by Application (%), 2024 VS 2031

Figure 51. Medical 3D Bioprinting Industrial Chain

Figure 52. Medical 3D Bioprinting Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Medical 3D Bioprinting market? zhanKai

The top companies in the global Medical 3D Bioprinting market are 3D Systems、GE Healthcare、ExOne.

Related Reports

Medical 3D Bioprinting - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medical 3D Bioprinting was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 144
USD 3950.00
(Single User License)
Global Medical 3D Bioprinting Market Research Report 2026
The global Medical 3D Bioprinting market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 146
USD 2900.00
(Single User License)
Global Medical 3D Bioprinting Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medical 3D Bioprinting market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 118
USD 4250.00
(Single User License)
Global Medical 3D Bioprinting Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Medical 3D Bioprinting market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 171
USD 4900.00
(Single User License)
Global Medical 3D Bioprinting Market Research Report 2025
The global market for Medical 3D Bioprinting was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 107
USD 2900.00
(Single User License)
Global Medical 3D Bioprinting Market Research Report 2024
Medical 3D bioprinting is the use of 3D printing-like techniques to combine cells, growth factors or biological materials to create biomedical parts, often with the aim of mimicking natural tissue characteristics. In general, 3D bioprinting can utilize a layer-by-layer approach to deposit materials called bioinks to create tissue-like structures that are subsequently used in various fields of medicine and tissue engineering. Bioprinting covers a wide range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to aid in the study of drugs and potential treatments.
Published Date: 2024-01-20
Pages: 105
USD 2900.00
(Single User License)
Medical 3D Bioprinting - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Medical 3D bioprinting is the use of 3D printing-like techniques to combine cells, growth factors or biological materials to create biomedical parts, often with the aim of mimicking natural tissue characteristics. In general, 3D bioprinting can utilize a layer-by-layer approach to deposit materials called bioinks to create tissue-like structures that are subsequently used in various fields of medicine and tissue engineering. Bioprinting covers a wide range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to aid in the study of drugs and potential treatments.
Published Date: 2024-01-11
Pages: 162
USD 3950.00
(Single User License)

Medical 3D Bioprinting - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medical 3D Bioprinting was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 144
USD 3950.00 (Single User License)
Global Medical 3D Bioprinting Market Research Report 2026
The global Medical 3D Bioprinting market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 146
USD 2900.00 (Single User License)
Global Medical 3D Bioprinting Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medical 3D Bioprinting market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 118
USD 4250.00 (Single User License)
Global Medical 3D Bioprinting Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Medical 3D Bioprinting market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 171
USD 4900.00 (Single User License)
Global Medical 3D Bioprinting Market Research Report 2025
The global market for Medical 3D Bioprinting was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 107
USD 2900.00 (Single User License)
Global Medical 3D Bioprinting Market Research Report 2024
Medical 3D bioprinting is the use of 3D printing-like techniques to combine cells, growth factors or biological materials to create biomedical parts, often with the aim of mimicking natural tissue characteristics. In general, 3D bioprinting can utilize a layer-by-layer approach to deposit materials called bioinks to create tissue-like structures that are subsequently used in various fields of medicine and tissue engineering. Bioprinting covers a wide range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to aid in the study of drugs and potential treatments.
Published: 2024-01-20
Pages: 105
USD 2900.00 (Single User License)
Medical 3D Bioprinting - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Medical 3D bioprinting is the use of 3D printing-like techniques to combine cells, growth factors or biological materials to create biomedical parts, often with the aim of mimicking natural tissue characteristics. In general, 3D bioprinting can utilize a layer-by-layer approach to deposit materials called bioinks to create tissue-like structures that are subsequently used in various fields of medicine and tissue engineering. Bioprinting covers a wide range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to aid in the study of drugs and potential treatments.
Published: 2024-01-11
Pages: 162
USD 3950.00 (Single User License)